Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Sandra Calvin currently holds 49,080 shares of Travere Therapeutics, Inc. (TVTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Sandra Calvin has been a net seller of TVTX stock. They have purchased $0 and sold $3.1M worth of shares.
Sandra Calvin's most recent insider trade was on Feb 3, 2026, when they sold 4,333 shares at $32.12 per share.
Sandra Calvin serves as Executive at Travere Therapeutics, Inc. (TVTX). They have executed 31 insider transactions totaling $3.1M over their tenure at the company.
Sandra Calvin holds the position of Executive at Travere Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 4 years and currently hold a stake valued at $0.
Sandra Calvin has shown a selling trading pattern, with $0 in total purchases and $3.1M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Sandra Calvin was on Nov 4, 2025, when they sold $2.4M worth of TVTX shares. This transaction involved 67,115 shares at $36.00 per share.
Sandra Calvin currently owns 49,080 shares of Travere Therapeutics, Inc. (TVTX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Sandra Calvin's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Sandra Calvin has 31 Form 4 filings on record as an insider at Travere Therapeutics, Inc..
Set alerts for Sandra Calvin and 40,000+ other insiders.